Evidence map›Paper›PMID 35740205›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Prevalence and Molecular Characteristics of Polymyxin-Resistant

Chenlu Xiao, Yan Zhu, Zhitao Yang, Dake Shi, Yuxing Ni, Li Hua, Jian Li

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Genomic variations in polymyxin-resistant Pseudomonas aeruginosa clinical isolates and their effects on polymyxin resistance.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  10. Boolean model of the gene regulatory network ofFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Chenlu XiaoDepartment of Laboratory Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.ORCID 0000-0002-2244-5524
Yan ZhuMonash Biomedicine Discovery Institute, Infection Program and Department of Microbiology, Monash University, Melbourne 3800, Australia.ORCID 0000-0001-7342-3782
Zhitao YangDepartment of Emergency, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Dake ShiDepartment of Infection Control, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Yuxing NiDepartment of Infection Control, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Li HuaSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.ORCID 0000-0002-6816-0786
Jian LiMonash Biomedicine Discovery Institute, Infection Program and Department of Microbiology, Monash University, Melbourne 3800, Australia.
Shanghai Jiao Tong University · CNAustralian Regenerative Medicine Institute · AU

Funding

Exploration and application of scientific, three-dimensional and accurate management mode of antibiotics(3D-AMS) (SHDC)22020203
6 · The paper itself

Abstract

Polymyxin-resistant

Indexed as

genomicsphenotypespolymyxin resistancePseudomonas aeruginosa

Identifiers

PMID35740205
PMCPMC9219935
OpenAlexW4282943323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.